122
A. A. Hassan, Y. R. Ibrahim, and A. M. Shawky
Vol 47
indole-CH), 7.12–7.68 (m, 4H, ArAH), 7.86 (br, 1H, oxadiaze-
pine-NH), 9.58 (br, 1H, OH), 11.62 (br, 1H, indole-NH); 13C
NMR: d 99.71(indole-CH), 121.98 (C-5a), 121.87, 123.35,
123.92 (C-6, 8 and 9), 127.14, 127.96 (ArACH), 130.55
(indole-C3a), 134.66, 137.12 (indole C-2 and C-7a), 152.46
(C-7), 156.81 (C-2), 169.80 (CO); MS m/z: 395/361 (Mþ, 29),
331 (26), 295 (38), 242 (21), 186 (12), 144 (62), 116 (76), 92
(100), 77 (83), 65 (41); Anal. Calcd. for C16H8Cl3N3O3
(396.61): C, 48.45; H, 2.03; Cl, 26.82; N, 10.59. Found C,
48.64; H, 1.91; Cl, 27.03; N, 10.77.
idine-CH), 138.42 (C-8a), 140.87 (C-4a), 146.42, 147.83 (pyri-
dine-C-2 and C-6), 152.71 (C-7), 156.84 (C-3), 171.42 (CO);
MS m/z: 366/370 (Mþ, 35), 332 (19), 296 (27), 224 (41), 196
(23), 106 (74), 78 (100); Anal. Calcd. for C15H12Cl2N4O3
(367.19): C, 49.07; H, 3.29; Cl, 19.31; N, 15.26. Found C,
48.84; H, 3.41; Cl, 19.07; N, 15.43.
5,6-Dichloro-7-hydroxy-N,N0-dimethyl-3-(pyridin-2-yl-1H-
benzo[e][1,3,4]oxadiazine-8-carboxamide (6e). Compound 6e
was obtained as brown crystals (0.073g, 18%), mp 301–303ꢁC
(methanol). IR: 3485 (OH), 3340-3295 (NH’s), 1690 (CO),
1630 (C¼¼N), 1600 (Ar-C¼¼C), 1085 (CAOAC); 1H NMR: d
3.41 (s, 6H, N(CH3)2), 6.64 (s, 1H, indole-CH), 7.26–7.81 (m,
5H, ArAH and oxadiazine-NH), 9.62 (br, 1H, OH), 11.71 (br,
1H, indole-NH); 13C NMR: d 36.45 (CH3), 98.95 (indole-CH),
106.88 (C-8), 122.32, 123.41 (C-5 and C-6), 126.37, 127.74
(Ar-CH), 130.71 (indole-C-3a), 135.07, 137.36 (indole-C-2 and
C-7a), 138.53 (C-8a), 141.07 (C-4a), 153.04 (C-7), 156.91 (C-
3), 171.26 (CO); MS m/z: 404/408 (Mþ, 25), 370 (32), 334
(12), 262 (46), 234 (19), 144 (56), 91 (76), 77 (100), 65 (85);
Anal. Calcd. for C18H14Cl2N4O3 (405.23): C, 53.35; H, 3.48;
Cl, 17.50; N, 13.83. Found C, 53.17; H, 3.61; Cl, 17.72; N,
14.05.
Reaction of substituted hydrazides 1a-e with (3). A solu-
tion of 1a-e (1.0 mmol) in 15 mL of dry DMF was added
dropwise with stirring to a solution of 3 (1.0 mmol) in 10 mL
of dry DMF. The reaction mixture was stirring for 72 h, during
which time it turned from faint orange into deep red. The pre-
cipitate of substituted naphtho[2,3-f][1,3,4]oxadiazepine-
5,6,11-(4H)-trione 16 was filtered and washed several times
with cold ethanol, and crystallized from suitable solvent.
2-Phenylnaphtho[2,3-f][1,3,4]oxadiazepine-5,6,11-(4H)-tri-
one (16a). Compound 16a was obtained as reddish brown
crystals (0.280g, 88%), mp 289–291ꢁC (acetonitrile). IR: 3230
(NH), 1710, 1685 (CO), 1620 (C¼¼N), 1585 (ArAC¼¼C), 1090
(CAOAC); 1H NMR: d 7.14–7.76 (m, 5H, ArAH), 7.84 (br,
1H, oxadiazepine-NH), 8.04–8.21 (m, 4H, ArAH); 13C NMR:
d 126.49, 128.84, 129.12, 134.61, 136.66 (ArACH), 131.45,
132.45, 132.17, 141.36 (ArAC), 156.86 (C-2), 169.64 (oxadia-
zepine-CO), 187.44, 187.78 (C-6 and C-11); ms m/z: 318
(Mþ, 46), 213 (26), 185 (61), 105 (81), 104 (76), 77 (100), 65
(67); Anal. Calcd. for C18H10N2O4 (318.28): C, 67.92; H,
3.17; N, 8.80. Found C, 68.14; H, 3.06; N, 9.04.
5,6-Dichloro-7-hydroxy-N,N0-dimethyl-3-phenyl-1H-benzo[e]
[1,3,4]oxadiazine-8-carboxamide (6a). Compound 6a was
obtained as deep red brown crystals (0.062g, 17%), mp 248–
250ꢁC (acetonitrile). IR: 3485 (OH), 3290 (NH), 1690 (CO),
1
1625 (C¼¼N), 1585 (ArAC¼¼C), 1080 (CAOAC); H NMR: d
3.44 (s, 6H, N(CH3)2), 7.24–7.79 (m, 6H, ArAH and oxadia-
zine-NH), 9.67 (br, 1H, OH); 13C: d 36.29 (CH3), 106.83 (C-
8), 122.27, 123.14 (C-5 and C-6), 127.21, 128.54, 130.16 (Ar-
CH), 134.27 (Ar-C), 138.44 (C-8a), 141.11 (C-4a), 152.51 (C-
7), 156.76 (C-3), 171.41 (CO); MS m/z: 365/369 (Mþ, 41),
329 (18), 257 (44), 193 (29), 105 (81), 77 (100), 65 (74);
Anal. Calcd. for C16H13Cl2N3O3 (366.20): C, 52.48; H, 3.58;
Cl, 19.36; N, 11.47. Found C, 52.66; H, 3.45; Cl, 19.59; N,
11.65.
5,6-Dichloro-7-hydroxy-N,N0-dimethyl-3-(thio-phen-2-yl-1H-
benzo[e][1,3,4]oxadiazine-8-carbox-amide (6b). Compound 6b
was obtained as reddish brown crystals (0.067g, 18%), mp
276–278ꢁC (ethanol). IR: 3470 (OH), 3310 (NH), 1685 (CO),
1
1630 (C¼¼N), 1590 (ArAC¼¼C), 1085 (CAOAC); H NMR: d
3.36 (s, 6H, N(CH3)2), 7.11–7.39 (m, 3H, thiophene-H), 7.71
(br, 1H, oxadiazine-NH), 9.70 (br, 1H, OH); 13C: d 36.41
(CH3), 107.12 (C-8), 121.94, 123.32 (C-5 and C-6), 126.22,
127.56, 127.84 (thiophene-CH), 130.12 (thiophene-C), 138.51
(C-8a), 140.97 (C-4a), 152.46 (C-7), 156.81 (C-3), 171.23
(CO); ms m/z: 371/375 (Mþ, 26), 336 (29), 300 (12), 264
(21), 153 (8), 111 (100), 83 (76); Anal. Calcd. for
C14H11Cl2N3O3S (372.23): C, 45.17; H, 2.98; Cl, 19.05; N,
11.29; S, 8.61. Found C, 44.94; H, 3.10; Cl, 18.88; N, 11.41;
S, 8.83.
5,6-Dichloro-7-hydroxy-N,N0-dimethyl-3-(thio-phen-2-yl-1H-
benzo[e][1,3,4]oxadiazine-8-carbox-amide (6c). Compound 6c
was obtained as brown crystals (0.078g, 22%), mp 235–237ꢁC
(ethanol). IR: 3480 (OH), 3300 (NH), 1680 (CO), 1625
2-(Thiophen-2-yl)naphtho[2,3-f][1,3,4]oxadiaz-epine-5,6,11-
(4H)-trione (16b). Compound 16b was obtained as brown
crystals (0.272 g, 84%), mp 307–309ꢁC (ethanol). IR: 3245
(NH), 1715, 1680 (CO), 1625 (C¼¼N), 1585 (Ar-C¼¼C), 1080
(C-O-C); 1H NMR: d 7.08–7.46 (m, 3H, thiophene-H), 7.80
(br, 1H, oxadiazepine-NH), 8.05–8.19 (m, 4H, ArAH); 13C
NMR: d 126.23, 127.76, 128.33, (thiophene-CH), 129.36,
136.94 (Ar-CH), 131.64, 131.16, 141.19 (ArAC), 156.80 (C-
2), 169.58 (oxadiazepine-CO), 187.39, 187.68 (C-6 and C-11);
ms m/z: 324 (Mþ, 23), 213 (34), 185 (48), 111 (100), 104
(56), 77 (86), 65 (61); Anal. Calcd. for C16H8N2O4S (324.31):
C, 59.26; H, 2.49; N, 8.64; S, 9.89. Found C, 59.09; H, 2.61;
N, 8.43; S, 10.04.
1
(C¼¼N), 1590 (ArAC¼¼C), 1085 (CAOAC); Hnmr: d 3.40 (s,
6H, N(CH3)2), 6.95–7.35 (m, 3H, furan-H), 7.69 (br, 1H, oxa-
diazine-NH), 9.67 (br, 1H, OH); 13C: d 36.38 (CH3), 106.91
(C-8), 122.18, 123.27 (C-5 and C-6), 125.96, 126.47 (furan-
CH), 138.36 (C-8a), 141.12 (C-4a), 142.76, 143.63 (furan-C-2
and C-5), 152.64 (C-7), 156.77 (C-3), 171.34 (CO); MS m/z:
355/359 (Mþ, 27), 320 (42), 284 (18), 212 (37), 117 (52), 95
(100), 67 (68); Anal. Calcd. for C14H11Cl2N3O4 (356.16): C,
47.21; H, 3.11; Cl, 19.91; N, 11.80. Found C, 47.44; H, 2.98;
Cl, 20.08; N, 12.02.
5,6-Dichloro-7-hydroxy-N,N0-dimethyl-3-(pyridin-2-yl-1H-
benzo[e][1,3,4]oxadiazine-8-carboxamide
(6d). Compound
6d was obtained as brown crystals (0.062g, 17%), mp 261–
263ꢁC (acetonitrile). IR: 3490 (OH), 3315 (NH), 1690 (CO),
1630 (C¼¼N), 1585 (ArAC¼¼C), 1080 (CAOAC); 1H: d 3.38
(s, 6H, N(CH3)2), 7.36A8.48 (m, 5H, pyridine-H and oxadia-
zine-NH), 9.74 (br, 1H, OH); 13C: d 36.44 (CH3), 107.09 (C-
8), 122.28, 123.46 (C-5 and C-6), 127.16, 128.91, 130.28 (pyr-
2-(Furan-2-yl)naphtho[2,3-f][1,3,4]oxadiazepine-5,6,11-(4H)-
trione (16c). Compound 16c was obtained as brown crystals
(0.253 g, 82%), mp 274–276ꢁC (ethanol). IR: 3235 (NH),
1710, 1690 (CO), 1620 (C¼¼N), 1590 (ArAC¼¼C), 1085
(CAOAC); 1H: d 6.97–7.38 (m, 3H, furan-H), 7.78 (br, 1H,
oxadiazepine-NH), 8.00–8.22 (m, 4H, ArAH); 13C NMR: d
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet